IDEAYA Biosciences (IDYA) Free Cash Flow (2018 - 2026)

IDEAYA Biosciences has disclosed Free Cash Flow across 9 years of filings, most recently posting -$76.1 million for Q1 2026.

• Free Cash Flow for Q1 2026 came in at -$76.1 million, down 24.82% year-over-year; the trailing twelve-month figure through Mar 2026 was -$88.6 million (up 66.7% YoY), and the FY2025 annual result was -$73.5 million, up 70.5% from the prior year.
• Free Cash Flow came in at -$76.1 million for Q1 2026 at IDEAYA Biosciences, up from -$92.2 million in the prior quarter.
• In the past five years, Free Cash Flow ranged from a high of $143.6 million in Q3 2025 to a low of -$120.4 million in Q4 2024.
• The 5-year median for Free Cash Flow is -$32.7 million (2024), against an average of -$35.5 million.
• Across the five-year window, Free Cash Flow tumbled 389.62% in 2024 and soared 376.41% in 2025, its largest moves.
• IDEAYA Biosciences' Free Cash Flow stood at -$20.3 million in 2022, then slipped by 21.05% to -$24.6 million in 2023, then plunged by 389.62% to -$120.4 million in 2024, then increased by 23.38% to -$92.2 million in 2025, then advanced by 17.45% to -$76.1 million in 2026.
• The last three Free Cash Flow figures came in at -$76.1 million (Q1 2026), -$92.2 million (Q4 2025), and $143.6 million (Q3 2025), per Business Quant data.